XML 26 R13.htm IDEA: XBRL DOCUMENT
v3.21.2

Fair Value Measurements | 6 Months Ended
--- | ---
Jun. 30, 2021
Fair Value Disclosures [Abstract] |
Fair Value Measurements | Fair Value Measurements The following fair value hierarchy table categorizes information regarding our financial assets and liabilities measured at fair value on a recurring basis (in millions):
| Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3) |  | Total
As of December 31, 2020 (Predecessor) |  |  |  |  |  |  |
Supplemental executive retirement plan assets | 22.6 |  |  | — |  |  | — |  |  | 22.6 |
Total financial assets | $ | 22.6 |  |  | $ | — |  |  | $ | — |  |  | $ | 22.6 |
Supplemental Executive Retirement Plan Assets Our supplemental executive retirement plans (the "SERP") are non-qualified plans that provided eligible employees an opportunity to defer a portion of their compensation for use after retirement. The SERP were frozen to the entry of new participants in November 2019 and to future compensation deferrals as of January 1, 2020. Assets held in a rabbi trust maintained for the SERP are marketable securities measured at fair value on a recurring basis using Level 1 inputs and were included in other assets, net, on our Condensed Consolidated Balance Sheets as of December 31, 2020. The fair value measurements of assets held in the SERP were based on quoted market prices. Pursuant to the plan of reorganization, the assets held in the rabbi trust maintained for the SERP were liquidated upon emergence from Chapter 11 Cases and used to satisfy the claims of creditors. Other Financial Instruments The carrying values and estimated fair values of our debt instruments were as follows (in millions):
| Successor |  | Predecessor
| June 30, 2021 |  | December 31, 2020
| Carrying Value |  | Estimated Fair Value |  | Carrying Value |  | Estimated Fair Value
Secured first lien notes due 2028 | $ | 544.8 |  |  | $ | 570.1 |  |  | $ | — |  |  | $ | — |
6.875% Senior notes due 2020 | — |  |  | — |  |  | 122.9 |  |  | 8.6 |
4.70% Senior notes due 2021 | — |  |  | — |  |  | 100.7 |  |  | 4.5 |
4.875% Senior notes due 2022 | — |  |  | — |  |  | 620.8 |  |  | 32.9 |
3.00% Exchangeable senior notes due 2024(1) | — |  |  | — |  |  | 849.5 |  |  | 76.5 |
4.50% Senior notes due 2024 | — |  |  | — |  |  | 303.4 |  |  | 13.7 |
4.75% Senior notes due 2024 | — |  |  | — |  |  | 318.6 |  |  | 18.8 |
8.00% Senior notes due 2024 | — |  |  | — |  |  | 292.3 |  |  | 12.9 |
5.20% Senior notes due 2025 | — |  |  | — |  |  | 333.7 |  |  | 12.7 |
7.375% Senior notes due 2025 | — |  |  | — |  |  | 360.8 |  |  | 20.9 |
7.75% Senior notes due 2026 | — |  |  | — |  |  | 1,000.0 |  |  | 44.0 |
7.20% Debentures due 2027 | — |  |  | — |  |  | 112.1 |  |  | 5.7 |
7.875% Senior notes due 2040 | — |  |  | — |  |  | 300.0 |  |  | 21.0 |
5.40% Senior notes due 2042 | — |  |  | — |  |  | 400.0 |  |  | 23.6 |
5.75% Senior notes due 2044 | — |  |  | — |  |  | 1,000.5 |  |  | 38.0 |
5.85% Senior notes due 2044 | — |  |  | — |  |  | 400.0 |  |  | 26.0 |
Amounts borrowed under Revolving Credit Facility(2) | — |  |  | — |  |  | 581.0 |  |  | 581.0 |
Total debt | $ | 544.8 |  |  | $ | 570.1 |  |  | $ | 7,096.3 |  |  | $ | 940.8 |
Less : Liabilities Subject to Compromise(3) | — |  |  | — |  |  | 7,096.3 |  |  | 940.8 |
Total long-term debt | $ | 544.8 |  |  | $ | 570.1 |  |  | $ | — |  |  | $ | — |
(1) For the Predecessor, the 3% exchangeable senior notes due 2024 (the "2024 Convertible Notes") were exchangeable into cash, our Class A ordinary shares or a combination thereof. The 2024 Convertible Notes were separated, at issuance, into their liability and equity components on our Condensed Consolidated Balance Sheet. The equity component was initially recorded to additional paid-in capital and as a debt discount and the discount was being amortized to interest expense over the life of the instrument. As discussed above, the carrying amount at December 31, 2020 represented the aggregate principal amount of these notes as of the Petition Date and were classified as Liabilities Subject to Compromise in our Condensed Consolidated Balance Sheets as of December 31, 2020. The Predecessor discontinued accruing interest on these notes as of the Petition Date. The equity component was $220.0 million and was classified as Additional Paid-in Capital as of December 31, 2020. On the Effective Date, in accordance with the plan of reorganization, all outstanding obligations under the 2024 Convertible Notes were cancelled and the equity component was written off to retained earnings. (2) In addition to the amount borrowed above, the Predecessor had $27.0 million in undrawn letters of credit issued under the Revolving Credit Facility as of December 31, 2020. On the emergence date, in accordance with the plan of reorganization, all undrawn letters of credit issued under the Revolving Credit Facility were collateralized pursuant to the terms of the Revolving Credit Facility. As of June 30, 2021, we had $22.0 million of collateralized letters of credit issued to lenders of the predecessor Revolving Credit Facility. (3) As discussed in “Note 2 - Chapter 11 Proceedings” and “Note 3 - Fresh Start Accounting,” since the commencement of the Chapter 11 Cases on August 19, 2020 and through April 30, 2021, the Company operated as a debtor-in-possession under the jurisdiction of the Bankruptcy Court and in accordance with the provisions of the Bankruptcy Code. Accordingly, all of our long-term debt obligations were presented as Liabilities Subject to Compromise in our Condensed Consolidated Balance Sheets as of December 31, 2020. All unamortized debt discounts, premiums or issuance costs related to our long-term debt obligations were written off to reorganization items as of the Petition Date in 2020. The estimated fair values of the Successor's First Lien Notes and the Predecessor's Senior Notes were determined using quoted market prices, which are level 1 inputs. The estimated fair value of our notes receivable was estimated by using an income approach to value the forecasted cash flows attributed to the note receivable using a discount rate based on comparable yield with a country-specific risk premium The estimated fair values of our cash and cash equivalents, restricted cash, accounts receivable and trade payables approximated their carrying values as of June 30, 2021 and December 31, 2020. As discussed above, the carrying amount at December 31, 2020 represents the Predecessor's outstanding borrowings as of the Petition Date and are classified as Liabilities Subject to Compromise in our Condensed Consolidated Balance Sheets as of December 31, 2020. We discontinued accruing interest on our indebtedness as of the Petition Date.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration